Search clinical trials for: VMAT2

Total 5 results

Neurocrine Biosciences

Recruiting

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Schizophrenia

United States, Bulgaria, Serbia
Neurocrine Biosciences

Terminated

Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia

Schizophrenia

United States
Neurocrine Biosciences
Huntington Study Group

Completed

Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease (KINECT-HD)

Chorea, Huntington

United States, Canada
Chang Gung Memorial Hospital

Completed

18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging (8F-DTBZ)

Parkinson's Disease

Taiwan
Neurocrine Biosciences

Recruiting

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Cerebral Palsy | Dyskinesia

United States, Argentina, Poland, Spain

3

Subscribe